Healthpeak Properties, Inc. $DOC Shares Purchased by Inspire Advisors LLC

Inspire Advisors LLC increased its position in shares of Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 121.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 52,059 shares of the real estate investment trust’s stock after purchasing an additional 28,577 shares during the quarter. Inspire Advisors LLC’s holdings in Healthpeak Properties were worth $912,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Healthpeak Properties by 584.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock valued at $186,405,000 after purchasing an additional 7,872,150 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Healthpeak Properties during the first quarter worth $124,113,000. Invesco Ltd. raised its position in shares of Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after buying an additional 3,967,830 shares during the last quarter. Nordea Investment Management AB lifted its stake in shares of Healthpeak Properties by 7,444.0% in the second quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock worth $67,871,000 after buying an additional 3,871,201 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Healthpeak Properties by 57.8% in the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock worth $136,785,000 after buying an additional 2,477,307 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOC. Weiss Ratings cut shares of Healthpeak Properties from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, November 12th. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a report on Monday, September 15th. Wells Fargo & Company dropped their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 27th. Evercore ISI set a $22.00 price target on Healthpeak Properties in a report on Monday, September 15th. Finally, Robert W. Baird reduced their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Healthpeak Properties presently has an average rating of “Moderate Buy” and a consensus price target of $20.82.

Check Out Our Latest Report on Healthpeak Properties

Healthpeak Properties Stock Performance

NYSE:DOC opened at $17.70 on Wednesday. The company’s 50-day moving average is $18.32 and its two-hundred day moving average is $17.83. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $22.71. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.28. The firm has a market capitalization of $12.30 billion, a price-to-earnings ratio of -353.83, a PEG ratio of 3.84 and a beta of 1.10.

Healthpeak Properties (NYSE:DOCGet Free Report) last released its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The firm had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. During the same quarter in the previous year, the company earned $0.45 EPS. The business’s revenue for the quarter was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) dividend on an annualized basis and a yield of 6.9%. Healthpeak Properties’s payout ratio is currently -2,440.00%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Stories

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOCFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.